Successful Treatment of Severe Plaque Psoriasis in an Adolescent With a Combination of Methotrexate and Acitretin: A Case Report. [PDF]
CureusYildirim MA.
europepmc +1 more source
Selective Targeting of IL‐1RAP‐Dependent Eosinophilic Inflammation in Allergic Fungal Airway Disease
Allergy, Volume 81, Issue 4, Page 1302-1305, April 2026.
Thomas J. Williams +7 more
wiley +1 more source
Cost-effectiveness of deucravacitinib versus apremilast of moderate-to-severe plaque psoriasis in China. [PDF]
BMC Health Serv ResTang B, Liu R, Hu S.
europepmc +1 more source
The role of Janus kinase signaling in graft-versus-host disease and graft versus leukemia [PDF]
, 2018 Choi, Jaebok +3 more
core +2 more sources
Secukinumab compared to ixekizumab in biologic-naïve Chinese individuals afflicted with moderate-to-severe plaque psoriasis: A retrospective single-center analysis. [PDF]
Medicine (Baltimore)Zhao D.
europepmc +1 more source
Association of skin microbiome with interleukin-23 in patients with plaque psoriasis. [PDF]
Postepy Dermatol AlergolSabry HH +3 more
europepmc +1 more source
Cohort study on the survival of methotrexate and acitretin treatment in patients with plaque psoriasis: experience from a single center. [PDF]
An Bras DermatolBrommonschenkel CC +3 more
europepmc +1 more source
Paediatric psoriasis and biologics: An evidence gap in plain sight
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 4, Page 556-557, April 2026.
Stephan Traidl, Sascha Gerdes
wiley +1 more source
Bimekizumab Impact on Patient-Reported Outcomes in Plaque Psoriasis: 4-Year Results from BE SURE, BE VIVID, BE READY, and BE BRIGHT. [PDF]
Dermatol Ther (Heidelb)Armstrong A +10 more
europepmc +1 more source
Real-World Benefit of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis: Findings from a Systematic Literature Review and Meta-Analysis. [PDF]
Dermatol Ther (Heidelb)Gottlieb S +8 more
europepmc +1 more source